Lapatinib Supplier-Buyer Network — Trade Flow Analysis

Name: Lapatinib Supplier-Buyer Trade Network Dataset — 86+ Indian Exporters, 12+ Importers, 49+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Lapatinib supplier network, Lapatinib buyers, pharmaceutical export India, Lapatinib trade data

TransData Nexus

Lapatinib

India Pharmaceutical Trade Intelligence

$5.4M86 Suppliers49 CountriesHS 30049099

ExportsIndia → UNITED STATES54.4%India → UNITED ARAB30.5%

ImportsROMANIA → India$590.4K SWITZERLAND → India$47.8K

#1 Supplier: NATCO PHARMA

Who Supplies Lapatinib? Top Manufacturers & Buyers 2026 — NATCO PHARMA LIMITED Leads | TransData Nexus | TransData Nexus

1NATCO PHARMA LIMITED

NATCO PHARMA LIMITED is the first-largest Lapatinib exporter from India, with a market share of 32.8% and a total export value of $1.8M across 22 shipments. Their average shipment value of $79.7K is above the market average of $17.8K, suggesting premium or bulk contract pricing.

NATCO PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• UPS — $852.1K across 11 shipments (48.6% of this supplier's total exports)

• UPS SUPPLY CHAIN SOL — $840.2K across 11 shipments (47.9% of this supplier's total exports)

• ONE PHARMA MEDICS — $47.7K across 1 shipments (2.7% of this supplier's total exports)

• EVEREST BANK LTD — $10.0K across 0 shipments (0.6% of this supplier's total exports)

• EVEREST BANK LIMITED — $4.2K across 0 shipments (0.2% of this supplier's total exports)

Key Insight: NATCO PHARMA LIMITED's per-shipment value of $79.7K is 347% above the market average of $17.8K, consistent with large-order contracts or value-added formulations.

2BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED

BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED is the second-largest Lapatinib exporter from India, with a market share of 5.7% and a total export value of $303.4K across 12 shipments. Their average shipment value of $25.3K is above the market average of $17.8K, suggesting premium or bulk contract pricing.

BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• AMINCORP — $119.5K across 5 shipments (39.4% of this supplier's total exports)

• TOROPH — $99.4K across 4 shipments (32.8% of this supplier's total exports)

• TOROPH — $70.1K across 3 shipments (23.1% of this supplier's total exports)

• TANEPVLT — $14.4K across 1 shipments (4.7% of this supplier's total exports)

Key Insight: BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED's per-shipment value of $25.3K is 42% above the market average of $17.8K, consistent with large-order contracts or value-added formulations.

3MEDWISE OVERSEAS PRIVATE LIMITED

MEDWISE OVERSEAS PRIVATE LIMITED is the third-largest Lapatinib exporter from India, with a market share of 1.6% and a total export value of $85.5K across 3 shipments. Their average shipment value of $28.5K is above the market average of $17.8K, suggesting premium or bulk contract pricing.

MEDWISE OVERSEAS PRIVATE LIMITED serves 2 named buyers in our database. M S DROGUERIA PERU S is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• M S DROGUERIA PERU S — $85.5K across 3 shipments (100.0% of this supplier's total exports)

• NA — $0 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: MEDWISE OVERSEAS PRIVATE LIMITED's per-shipment value of $28.5K is 60% above the market average of $17.8K, consistent with large-order contracts or value-added formulations.

4IKRIS PHARMA NETWORK PRIVATE LIMITED

IKRIS PHARMA NETWORK PRIVATE LIMITED is the fourth-largest Lapatinib exporter from India, with a market share of 0.8% and a total export value of $42.9K across 3 shipments. Their average shipment value of $14.3K is below the market average of $17.8K, reflecting a high-volume, competitive pricing strategy.

IKRIS PHARMA NETWORK PRIVATE LIMITED serves 1 named buyer in our database. CENTRE NATIONAL DE L is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• CENTRE NATIONAL DE L — $42.9K across 3 shipments (100.0% of this supplier's total exports)

Key Insight: IKRIS PHARMA NETWORK PRIVATE LIMITED operates with high shipment frequency (3 shipments) at a per-shipment value of $14.3K, indicating a broad distribution network with many smaller, regular orders.

5SHREE KRISHNA LIFECARE

SHREE KRISHNA LIFECARE is the fifth-largest Lapatinib exporter from India, with a market share of 0.5% and a total export value of $25.7K across 7 shipments. Their average shipment value of $3.7K is below the market average of $17.8K, reflecting a high-volume, competitive pricing strategy.

SHREE KRISHNA LIFECARE serves 3 named buyers in our database. THE MANAGER - EKINOKSECZA DEPOSU SAN TIC AS is the dominant customer, accounting for 96.2% of this supplier's tracked business. Top customers include:

• THE MANAGER - EKINOKSECZA DEPOSU SAN TIC AS — $24.7K across 7 shipments (96.2% of this supplier's total exports)

• TO THE ORDER OF THE — $625 across 0 shipments (2.4% of this supplier's total exports)

• THE MANAGER - BBJ CO — $364 across 0 shipments (1.4% of this supplier's total exports)

Key Insight: SHREE KRISHNA LIFECARE operates with high shipment frequency (7 shipments) at a per-shipment value of $3.7K, indicating a broad distribution network with many smaller, regular orders.

6MBA PHARMACEUTICALS PRIVATE LIMITED

MBA PHARMACEUTICALS PRIVATE LIMITED is the fifth-largest Lapatinib exporter from India, with a market share of 0.4% and a total export value of $22.6K across 6 shipments. Their average shipment value of $3.8K is below the market average of $17.8K, reflecting a high-volume, competitive pricing strategy.

MBA PHARMACEUTICALS PRIVATE LIMITED serves 1 named buyer in our database. TO is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• TO — $22.6K across 6 shipments (100.0% of this supplier's total exports)

Key Insight: MBA PHARMACEUTICALS PRIVATE LIMITED operates with high shipment frequency (6 shipments) at a per-shipment value of $3.8K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Lapatinib imports from India, with a total trade value of $2.9M across 2 shipments — representing a 54.4% share of all Lapatinib exports. The average shipment value of $1.5M is above the global average of $17.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Lapatinib importers in United States: M/S. UPS is the largest buyer, accounting for 23.7% ($690.7K) of this market's total imports.

• M/S. UPS — $690.7K (23.7% of United States's total)

Key Insight: United States's per-shipment average of $1.5M (8065% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Lapatinib imports from India.

Primary Market

Secondary Market

2United Arab Emirates

United Arab Emirates ranks as the second-largest destination for Lapatinib imports from India, with a total trade value of $1.6M across 0 shipments — representing a 30.5% share of all Lapatinib exports. The average shipment value of $1.6M is above the global average of $17.8K, indicating high-value procurement contracts or branded formulations.

Key Insight: United Arab Emirates's per-shipment average of $1.6M (9051% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Arab Emirates is a key market for Lapatinib imports from India.

Primary Market

Secondary Market

3Kazakhstan

Kazakhstan ranks as the third-largest destination for Lapatinib imports from India, with a total trade value of $169.5K across 5 shipments — representing a 3.2% share of all Lapatinib exports. The average shipment value of $33.9K is above the global average of $17.8K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Lapatinib importers in Kazakhstan: TOROPH is the largest buyer, accounting for 58.7% ($99.4K) of this market's total imports.

• TOROPH — $99.4K (58.7% of Kazakhstan's total)

• TOROPH , — $70.1K (41.3% of Kazakhstan's total)

Key Insight: Kazakhstan's per-shipment average of $33.9K (90% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Kazakhstan is a key market for Lapatinib imports from India.

Primary Market

Secondary Market

4Philippines

Philippines ranks as the fourth-largest destination for Lapatinib imports from India, with a total trade value of $120.7K across 5 shipments — representing a 2.3% share of all Lapatinib exports. The average shipment value of $24.1K is above the global average of $17.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Lapatinib importers in Philippines: AMINCORP is the largest buyer, accounting for 99.0% ($119.5K) of this market's total imports.

• AMINCORP — $119.5K (99.0% of Philippines's total)

Key Insight: Philippines's per-shipment average of $24.1K (35% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Philippines is a key market for Lapatinib imports from India.

Primary Market

Secondary Market

5Peru

Peru ranks as the fifth-largest destination for Lapatinib imports from India, with a total trade value of $85.5K across 0 shipments — representing a 1.6% share of all Lapatinib exports. The average shipment value of $85.5K is above the global average of $17.8K, indicating high-value procurement contracts or branded formulations.

Key Insight: Peru's per-shipment average of $85.5K (379% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Peru is a key market for Lapatinib imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Lapatinib.
2.Flow Mapping: 86 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 300 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 49 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

300 Verified Shipments

86 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Lapatinib

Lapatinib

Who Supplies Lapatinib? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Lapatinib? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Lapatinib Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1NATCO PHARMA LIMITED

2BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED

3MEDWISE OVERSEAS PRIVATE LIMITED

4IKRIS PHARMA NETWORK PRIVATE LIMITED

5SHREE KRISHNA LIFECARE

6MBA PHARMACEUTICALS PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Lapatinib Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Lapatinib Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2United Arab Emirates

3Kazakhstan

4Philippines

5Peru

People Also Ask — Lapatinib Supplier & Trade Network

Lapatinib Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology